Electromed, Inc. (ELMD)

Market Cap	303.30M +87.0%
Revenue (ttm)	71.75M +16.8%
Net Income	10.10M +41.1%
EPS	1.17 +48.5%
Shares Out	8.28M
PE Ratio	31.27
Forward PE	26.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,519
Open	37.25
Previous Close	37.72
Day's Range	36.31 - 38.51
52-Week Range	17.73 - 40.00
Beta	0.39
Analysts	Strong Buy
Price Target	40.33 (+10.1%)
Earnings Date	May 12, 2026

About ELMD

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 13, 2010
• Employees: 180
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: ELMD
• Website: https://smartvest.com

Financial Performance

In fiscal year 2025, Electromed's revenue was $64.00 million, an increase of 16.97% compared to the previous year's $54.72 million. Earnings were $7.54 million, an increase of 46.35%.

Analyst Summary

According to 3 analysts, the average rating for ELMD stock is "Strong Buy." The 12-month stock price target is $40.33, which is an increase of 10.10% from the latest price.

Price Target

$40.33

(10.10% upside)

Analyst Consensus: Strong Buy